Correlation between decreased motor activity and dopaminergic degeneration in the ventrolateral putamen in monkeys receiving repeated MPTP administrations: A positron emission tomography study

[1]  A. Nambu,et al.  Differential activity patterns of putaminal neurons with inputs from the primary motor cortex and supplementary motor area in behaving monkeys. , 2011, Journal of neurophysiology.

[2]  Anatol C. Kreitzer,et al.  Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry , 2010, Nature.

[3]  Takuya Hayashi,et al.  Objective and quantitative evaluation of motor function in a monkey model of Parkinson's disease , 2010, Journal of Neuroscience Methods.

[4]  C. Cavada,et al.  Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study , 2010, Neurobiology of Disease.

[5]  S. Obayashi,et al.  Progressive changes of pre‐ and post‐synaptic dopaminergic biomarkers in conscious MPTP‐treated cynomolgus monkeys measured by positronemission tomography , 2007, Synapse.

[6]  Ramon Casanova,et al.  Biological parametric mapping: A statistical toolbox for multimodality brain image analysis , 2007, NeuroImage.

[7]  Christer Halldin,et al.  Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  Daniel M. Togasaki,et al.  The Webcam system: a simple, automated, computer-based video system for quantitative measurement of movement in nonhuman primates , 2005, Journal of Neuroscience Methods.

[9]  M. Herrero,et al.  Measurement of motor disability in MPTP-treated macaques using a telemetry system for estimating circadian motor activity , 2004, Journal of Neuroscience Methods.

[10]  T. Araki,et al.  Role of Dopamine Transporter Against MPTP (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine) Neurotoxicity in Mice , 2003, Metabolic Brain Disease.

[11]  A. Nambu,et al.  Organization of corticostriatal motor inputs in monkey putamen. , 2002, Journal of neurophysiology.

[12]  V. Dhawan,et al.  Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: A PET study , 2002, Synapse.

[13]  J. Holden,et al.  Density and affinity of the dopamine D2 receptors in aged symptomatic and asymptomatic MPTP‐treated monkeys: PET studies with [11C]raclopride , 2002, Synapse.

[14]  V. Sossi,et al.  In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease , 2000, Annals of neurology.

[15]  Vesna Sossi,et al.  Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism , 2000, Journal of neurology, neurosurgery, and psychiatry.

[16]  J C Froment,et al.  Striatal D2 dopamine receptor status in Parkinson's disease: An [18F]dopa and [11C]Raclopride PET study , 1999, Movement disorders : official journal of the Movement Disorder Society.

[17]  Karl J. Friston,et al.  Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study. , 1999, Brain : a journal of neurology.

[18]  M. Inase,et al.  Corticostriatal projections from the somatic motor areas of the frontal cortex in the macaque monkey: segregation versus overlap of input zones from the primary motor cortex, the supplementary motor area, and the premotor cortex , 1998, Experimental Brain Research.

[19]  Vincent J. Cunningham,et al.  Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.

[20]  S J Kish,et al.  [11C]RTI‐32 PET studies of the dopamine transporter in early dopa‐naive Parkinson's disease , 1997, Neurology.

[21]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[22]  A. Antonini,et al.  [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease , 1994, Neurology.

[23]  G. Brownell,et al.  Dopamine Terminal Loss and Onset of Motor Symptoms in MPTP-Treated Monkeys: A Positron Emission Tomography Study with 11C-CFT , 1994, Experimental Neurology.

[24]  G. E. Alexander,et al.  Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.

[25]  Karl J. Friston,et al.  The Relationship between Global and Local Changes in PET Scans , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  O. Hornykiewicz,et al.  The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease , 1988, Neuroscience Letters.

[27]  S. L. Liles.  Activity of neurons in the putamen associated with wrist movements in the monkey , 1983, Brain Research.

[28]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[29]  Kevin J Black,et al.  Atlas template images for nonhuman primate neuroimaging: baboon and macaque. , 2004, Methods in enzymology.

[30]  N. Yanagisawa.  [Long-term therapy of Parkinson's disease]. , 1988, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.